The focus is not on quickly using a specific active ingredient, but on determining which treatment option is medically appropriate, tolerable, available, and suitable for long-term medical support
One question this raises for me is how to weigh a modest additional weight loss (12%) against higher GI adverse events, higher cost and long term tolerability
it also impacts the brain
However, if you take insulin, sulfonylureas, or meglitinides concurrently, hypoglycemia risk increases substantially
PYY 336 is responsible for the anorexigenic actions of PYY, as documented in infusion studies (111, 112) and together with GLP-1, seems to play a role in the decreased food intake and major weight loss seen after the bariatric surgery procedure, Roux-en-Y gastric bypass (111, 113)
BMI should not be used as a sole diagnostic tool